India
· Delayed Price · Currency is INR Rossari Biotech Statistics
Total Valuation
Rossari Biotech has a market cap or net worth of INR 38.78 billion. The enterprise value is 39.81 billion.
| Market Cap | 38.78B |
| Enterprise Value | 39.81B |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | Aug 16, 2024 |
Share Statistics
| Current Share Class | 55.37M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 17.62M |
Valuation Ratios
The trailing PE ratio is 28.43 and the forward PE ratio is 25.03.
| PE Ratio | 28.43 |
| Forward PE | 25.03 |
| PS Ratio | 1.86 |
| PB Ratio | 3.27 |
| P/TBV Ratio | 4.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 28.21 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.96, with an EV/FCF ratio of -188.96.
| EV / Earnings | 29.19 |
| EV / Sales | 1.91 |
| EV / EBITDA | 14.96 |
| EV / EBIT | 20.01 |
| EV / FCF | -188.96 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.94 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 0.82 |
| Debt / FCF | -10.35 |
| Interest Coverage | 11.12 |
Financial Efficiency
Return on equity (ROE) is 12.21% and return on invested capital (ROIC) is 9.63%.
| Return on Equity (ROE) | 12.21% |
| Return on Assets (ROA) | 7.14% |
| Return on Invested Capital (ROIC) | 9.63% |
| Return on Capital Employed (ROCE) | 14.56% |
| Revenue Per Employee | 46.23M |
| Profits Per Employee | 3.03M |
| Employee Count | 450 |
| Asset Turnover | 1.20 |
| Inventory Turnover | 4.50 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.64% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -0.64% |
| 50-Day Moving Average | 650.44 |
| 200-Day Moving Average | 778.84 |
| Relative Strength Index (RSI) | 61.11 |
| Average Volume (20 Days) | 6,067 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Rossari Biotech had revenue of INR 20.80 billion and earned 1.36 billion in profits. Earnings per share was 24.63.
| Revenue | 20.80B |
| Gross Profit | 6.47B |
| Operating Income | 1.98B |
| Pretax Income | 1.85B |
| Net Income | 1.36B |
| EBITDA | 2.65B |
| EBIT | 1.98B |
| Earnings Per Share (EPS) | 24.63 |
Balance Sheet
The company has 1.14 billion in cash and 2.18 billion in debt, giving a net cash position of -1.04 billion.
| Cash & Cash Equivalents | 1.14B |
| Total Debt | 2.18B |
| Net Cash | -1.04B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 11.85B |
| Book Value Per Share | 214.07 |
| Working Capital | 5.07B |
Cash Flow
In the last 12 months, operating cash flow was 1.37 billion and capital expenditures -1.59 billion, giving a free cash flow of -210.69 million.
| Operating Cash Flow | 1.37B |
| Capital Expenditures | -1.59B |
| Free Cash Flow | -210.69M |
| FCF Per Share | n/a |
Margins
Gross margin is 31.10%, with operating and profit margins of 9.52% and 6.56%.
| Gross Margin | 31.10% |
| Operating Margin | 9.52% |
| Pretax Margin | 8.90% |
| Profit Margin | 6.56% |
| EBITDA Margin | 12.74% |
| EBIT Margin | 9.52% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.07%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.07% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 2.03% |
| Buyback Yield | -0.08% |
| Shareholder Yield | -0.01% |
| Earnings Yield | 3.52% |
| FCF Yield | -0.54% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |